Drug Industry Daily
Oct. 8, 2012
| Vol.
11 No.
197
Supreme Court Faces Choice on Pay-for-Delay Cases
The FTC Thursday asked the Supreme Court to take up and overturn an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements between branded drug makers and generic competitors.
This article is viewable by subscribers only. To view this article, please select an option below.
|